key: cord-1044688-d1yyo22i
authors: Ryan, Jill; Wiyeh, Alison; Karamagi, Humphrey; Okeibunor, Joseph; Tumusiime, Prosper; Wiysonge, Charles Shey
title: A scoping review on research agendas to enhance prevention of epidemics and pandemics in Africa
date: 2020-11-24
journal: Pan Afr Med J
DOI: 10.11604/pamj.supp.2020.37.40.23458
sha: cbf46d7788fe7a838ba32c37a9248dfe6f853715
doc_id: 1044688
cord_uid: d1yyo22i

INTRODUCTION: research is not only needed to prioritise the best possible response during an epidemic and pandemic, it is also understood to be a core pillar of outbreak response. However, few African countries are equipped to perform the needed surveillance and research activities during an outbreak. Therefore, we mapped out research agendas aimed at increased research preparedness towards epidemics or pandemics in Africa. METHODS: eligible studies were searched for in in PubMed, Scopus, and Google Scholar. Additionally, grey literature was sought in Google, citation searches, as well as targeted sites such as the World Health Organization (WHO), Africa Centres for Disease Control and Prevention, African Union, and the Wellcome Trust. Searches were done in March 2020. RESULTS: the electronic searches yielded 7344 records, of which 34 articles were included in the study. The studies identified around 18 factors highlighted through various research agendas. Majority of the research agendas spoke to general epidemic preparedness and focused largely on understanding virus transmission such as its characteristics and dynamics, and the infrastructure needed to carry out vital research activities. CONCLUSION: the review highlights the research needs in order to carry out vital research work but to also bridge knowledge gaps and harmonize outbreak response from key stakeholders. However, Africa needs to create its own health research agendas and capacitate itself to conduct and lead these studies. African health research decisions must center on Africa, with African researchers taking the lead not only on the science produced but ensuring inclusive and equitable involvement from fellow researchers, and in engaging national health ministries as well as the communities.

Conducting valuable research during pandemics and epidemics is not only needed to prioritize the best possible response but is also acknowledged as a core pillar of outbreak response [1] . During recent public health crises, such as the 2009 H1N1 influenza pandemic, government leaders needed to make decisions at a time where information was limited and highly uncertain [2] . Effective processes were needed between stakeholders to facilitate the utilization of scientific information to assess each scenario, and ultimately identify interventions offering the most beneficial outcomes [2] . However, with emerging and reemerging infections such as Ebola, Zika, Influenza, and the subsets of coronavirus, there are challenges regarding rapid research output or to rapidly undertake intervention trials to inform practice and patient care [1, 3] . These challenges are linked to the unpredictable nature of the virus, as well as its time and location of onset [1, 3] . Thus, the need for scientific and research preparedness is unquestionable in its necessity when prioritizing effective outbreak responses [1, 2] .

The World Health Organization (WHO) has indicated its awareness regarding the need for such preparedness, and in a 2018 document on managing epidemics, they mention their global strategy and preparedness plan highlighted as their research and development blueprint [4] . The strategies highlighted in this document will aim to allow rapid activation of research and development activities which will fast-track the availability of effective diagnostic tests and treatment, averting large scale crises [4, 5] . However, when epidemics overlap and occur at the same time, the challenge is creating an efficient global response to increase multiple public health emergencies. Such a response requires integration from health, economic and global systems to prepare for said epidemics or outbreaks [6] . This proves difficult when not all countries are equipped to carry out these research activities and required surveillance, as is the case in many low-and middle-income settings in the African continent.

Outbreaks in Africa have shown time and time again, to be a cause of global concern [7]. Out of the 55 African countries, only 15 currently have institutions equipped to perform the functions of an effective National Public Health Institution (NPHI) which includes disease surveillance of diagnostic laboratories, capacity to activate response teams for outbreaks, as well as being operation centres for public health crises [7] . Equipping African NPHIs is vital for health security [7, 8] . With Africa´s 1.2 billion population expected to expand to 2.4 billion by 2050, this rapidly expanding population means greater urbanization but also increased informal settlements; where, already half of urban areas do not have access to sanitation, and even less have access to scheduled childhood vaccinations [7] . Furthermore, rapid population increase, and urbanization also means increased risk for outbreaks and limited response to address it. This is due primarily to Africa´s incapacity to swiftly and effectively manage these emergencies [7, 8] . The Africa Centres for Disease Control and Prevention (Africa CDC) estimates that Africa requires 2-3.5 billion US dollars per year to be adequately capitated for epidemic preparedness, yet only receives $700 million [7] . In this scoping review, research agendas aimed at increasing research preparedness toward epidemics or pandemics, which may facilitate and streamline effective response for emerging and re-emerging disease outbreak were mapped.

A scoping review maps the existing literature on a given topic and identifies key concepts and gaps in the existing research on that topic. In this scoping review we followed the methods proposed by Levac et al.

[9] and enhanced by Peters et al. [10] . We have used the preferred reporting items for systematic reviews and meta-analysis-extension for Scoping reviews (PRISMA-ScR) checklist to shape structure and content [11] .

Eligibility criteria: the inclusion criteria are structured according to the components suggested in Peters et al. [10] . Inclusion criteria were broken down into the following elements: participants, concepts, and context. Participants: African "think tank" organizations: African Union, WHO, United Nations (UN), United Nations Children Fund (UNICEF), and universities, focusing research on Africa.

Research agendas: research strategies which facilitate preparedness.

Epidemic: "a disease (infectious and noninfectious) that affects a large number of people, with a recent and substantial increase in the number of cases" [12].

Pandemic: an outbreak with characteristics which include wide geographic expansion, disease movement which can be traced from place to place, has high attack rates and explosiveness (multiple cases within short space of time); minimal population immunity; novelty (new or new variants of pathogen); it is infectious as well as severe [13] .

Context: within Africa; no specificity related to cultural factors, racial or sex-based factor, setting such as a health facility or school or discipline. Google was also used to search for additional grey literature, while searching for missing WHO documents. As noted in a paper by Godin et al. [15] , Google can be overwhelming owing to the immense information available and inconsistent website organization. For this reason, Godin and colleagues further stated that it is impossible to screen all retrieved results and as such one must rely on the power of the relevancy ranking within the Google search engines, which is to bring out the most relevant results to the top of the list [15] . The relevancy list generated by Google, is presented in a set number of pages to be screened in advance, ensuring consistency and time management and thus narrowing the search results to specific subject area allowing refined and targeted searching [15] . The first 10 pages of hits were screened (100 results), through title screen and the short text beneath the title, similar to the method used in Godin et al. [15] . The review strategy had been shaped using the PRESS (Peer Review of Electronic Search Strategies) 2015 guideline statement, which allowed the discovery of search errors and offers enhancements to the selection of subject headings and text words, resulting in additional studies [16] .

Study selection: selection criteria was based on the specifics of the research question and later refined with new familiarity on the subject matter through reading the studies. Clarity in decision-making of selection criteria was clarified using the following steps: i) initial team meetings were conducted every week to discuss inclusion and exclusion criteria. ii) More than one authors was used to clarify situations of disagreement to determine final inclusion. iii) Meetings between two authors (JR and CSW) were held at the beginning, midpoint and final stages of the abstract review process discussing challenges and uncertainties related to study selection and to go back and refine the search strategy if needed.

Extraction and charting the results: results were extracted and narratively described contextual or process-oriented information from each document, accompanied by a flow chart to show search decision and final selection ( Figure 1 ). Firstly, the data extraction sheet in tabular form summarized each study according to: 1) author(s), 2) year of publication, 3) country of focus, and 9) key message that relate to the review question. Furthermore, the extracted data has been translated into a logical and descriptive summary of the results linked to addressing the review question. As such the results have been presented below through a narrative synthesis.

Selection of sources of evidence: we found a collective 7344 publications from the database search, and an additional 15 documents from other means described in Figure 1 . After duplicate removal, 6032 records were screened at title and abstract level, resulting in the exclusion of 5952 records. The remaining 80 articles were assessed for eligibility. Of the 80 titles a further exclusion of 46 articles, with reasons, was undertaken, as shown in Figure 1 . One of the reasons for exclusion involved missed duplicates, which can occur as false negatives (duplicates which were to be deleted but were not) in reference managers [17] . After these exclusions, 34 articles were included in the review [18-52].

Characteristics of sources of evidence: of the included documents, 22 were journal articles, 7 were research frameworks, 3 were reports, and 2 were commentaries. Majority of the articles assessed the relevance of current epidemic research agendas and its alignment to context and current research needs. Furthermore, the journal article records also aimed in establishing research priorities and in showing the process and tools used to create these priorities. Commentaries focused on having research sites and networks established and strengthened, which would streamline barrier resolutions, case definitions, protocols, and create rapid exchange mechanisms for high quality data and samples to reduce duplication. The frameworks and reports set out establishing research areas for preparedness and in highlighting the need for strengthening infrastructure to carry out the research in a safe and effective manner.

Synthesized results: Table 2, Table 3 , and Table 4 highlights the key message of each document included in the study. Majority of the studies had focused their research agendas around understanding transmission and infrastructure. Studies which focused on transmission sought to understand the characterization, etiology, or pathogenesis of the disease so as to better identify the pathogen, how it may interplay with other disease (e.g. TB and diabetes or HIV associated TB), as well as to study disease interaction such as vector-virus interaction or if the pandemic goes from region to region, the impact this may Of the included studies, the broad manner in which transmission was addressed throughout the documents, illustrates the various levels at which one should understand the characteristics of the pathogen, and mechanisms of transmission in successful isolation and limiting of the disease spread [4] . Furthermore, understanding transmission falls part of early detection of which a new disease might mean new interventions [4] . This in turn links to infrastructure in building research capacity, which too was largely addressed by most of the documents, which would allow for mobilization and rapid deployment of and testing of candidate products within countries where outbreaks are most likely to occur [55] . An example of this lack of infrastructure goes back to the Ebola outbreaks, which delayed response in the form of vaccine and therapeutics ultimately resulting in a hindered outcome impact [55].

In having research agendas, we allow opportunities to bridge medium-and long-term knowledge gaps [56] . Yet in respect to epidemic research, research agendas create a harmonized response with key stakeholders. Epidemic research agendas allow high-quality research protocols and tools to be shared whilst inviting materials and samples from research partners in an ethical manner [56] . However, Africa needs to create its own health research agendas and capacitate itself to conduct and lead these studies, as the notion of 'safari science' whereby African scientists act as data gatherers for Western research agendas, is not an effective route any longer [57] . African health research decisions must center on Africa, with African researchers taking the lead not only on the science produced but ensuring inclusive and equitable involvement from fellow researchers, and in engaging national health ministries as well as the communities [57]. This engagement with community needs and contextualized interventions had been highlighted in four documents included in this study [18, 26, 46, 52] . These may in turn further build sustainability and local commitment, which must transcend the need of funders or any project [57].

Limitations: this review, though attempting a highly sensitive search to capture as much eligible evidence as possible, may not have located all sources, especially when searching grey literature, in which some documents may be missed.

It is vital for Africa to take the lead on its health decisions as well as lead the science in Africa's epidemic response. However, to do this we must ensure we are capacitated to do so and have the infrastructure for secure and adequate response and mobilization of real-time research and deployment of vaccines or other therapeutic products.

• Tables and figure   Table 1 : search strategy for PubMed Table 2 : summary of evidence for included studies addressing general epidemic research agendas Table 3 : summary of evidence for included studies addressing zoonotic epidemic research agendas Research to continue around tobacco control, but to assert more focus on trade agreements, prevention among women and girls, and to adequately address the impact of use (including long-term use) of new nicotine-delivery systems such as nicotine-based non-combustibles (including e-cigarettes). Research agenda to focus on the efficacy, efficiency, and the quality of HIV intervention implementation; be adaptive in strategies to cater to context to address diverse needs and minimize cost; for research to elevate the patient experience and to incorporate patient reported outcomes. 

A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot

Science preparedness and science response: perspectives on the dynamics of preparedness conference

Time required to initiate outbreak and pandemic observational research

World Health Organization. Managing epidemics: key facts about major deadly diseases

The authors acknowledge the support received from the World Health Organization Regional Office for Africa (AFRO) and the South African Medical Research Council (SAMRC) during the conduct and reporting of this study.

Real-time research and pandemic response and (((Algeria) or (Angola) or (Benin) or (Botswana) or (Burkina Faso) or (Burundi) or (Cameroon) or ((Canary Islands) or "Canary Islands") or ((Cape Verde) or "Cape Verde") or (Central African Republic) or (Chad) or (Comoros) or (Congo) or (Democratic Republic Congo) or (Djibouti) or (Egypt) or ((Equatorial Guinea) or "Equatorial Guinea") or (Eritrea) or (Ethiopia) or (Gabon)) or ((Gambia) or (Ghana) or (Guinea) or ((Guinea Bissau) or "Guinea Bissau") or (Ivory Coast) or ((Cote D'ivoire) or "Cote D'ivoire") or ((Cote Ivoire) or "Cote Ivoire") or (Kenya) or (Lesotho) or (Liberia) or (Libya) or (Libia) or (Jamahiriya) or (Jamahiryia) or (Madagascar) or (Malawi) or (Mali) or (Mauritania) or (Mauritius) or (Morocco)) or ((Mozambique) or (Mocambique) or (Namibia) or (Niger) or (Nigeria) or (Reunion) or (Rwanda) or ((Sao Tome) or "Sao Tome") or (Senegal) or (Seychelles) or ((Sierra Leone) or "Sierra Leone") or (Somalia) or ((South Africa) or "South Africa") or ((St Helena) or "St Helena") or (Sudan) or (Swaziland) or Eswatini or (Tanzania) or (Tanganyika) or (Togo) or (Tunisia)) or ((Uganda) or ((Western Sahara) or "Western Sahara") or (Zaire) or (Zambia) or (Zimbabwe) or (Africa[Mh]) or (South* and Africa*) or (West* and Africa*) or (East* and Africa*) or (North* and Africa*) or (Central* and Africa*) or (Sub Saharan Africa*) or (Subsaharan Africa*) or (Africa*))) not (((Guinea Pig*) or "Guinea Pig*") or ((Aspergillus Niger) or "Aspergillus Niger"))

The authors declare no competing interests. Islands) or "Canary Islands") or ((Cape Verde) or "Cape Verde") or (Central African Republic) or (Chad) or (Comoros) or (Congo) or (Democratic Republic Congo) or (Djibouti) or (Egypt) or ((Equatorial Guinea) or "Equatorial Guinea") or (Eritrea) or (Ethiopia) or (Gabon)) or ((Gambia) or (Ghana) or (Guinea) or ((Guinea Bissau) or "Guinea Bissau") or (Ivory Coast) or ((Cote D'ivoire) or "Cote D'ivoire") or ((Cote Ivoire) or "Cote Ivoire") or (Kenya) or (Lesotho) or (Liberia) or (Libya) or (Libia) or (Jamahiriya) or (Jamahiryia) or (Madagascar) or (Malawi) or (Mali) or (Mauritania) or (Mauritius) or (Morocco)) or ((Mozambique) or (Mocambique) or (Namibia) or (Niger) or (Nigeria) or (Reunion) or (Rwanda) or ((Sao Tome) or "Sao Tome") or (Senegal) or (Seychelles) or ((Sierra Leone) or "Sierra Leone") or (Somalia) or ((South Africa) or "South Africa") or ((St Helena) or "St Helena") or (Sudan) or (Swaziland) or Eswatini or (Tanzania) or (Tanganyika) or (Togo) or (Tunisia)) or ((Uganda) or ((Western Sahara) or "Western Sahara") or (Zaire) or (Zambia) or (Zimbabwe) or (Africa[Mh]) or (South* and Africa*) or (West* and Africa*) or (East* and Africa*) or (North* and Africa*) or (Central* and Africa*) or (Sub Saharan Africa*) or (Subsaharan Africa*) or (Africa*))) not (((Guinea Pig*) or "Guinea Pig*") or ((Aspergillus Niger) or "Aspergillus Niger"))